These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17208143)

  • 21. Neoadjuvant chemotherapy in muscle-invasive bladder cancer: ready for prime time?
    Pouessel D; Mongiat-Artus P; Culine S
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):288-94. PubMed ID: 23022113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.
    Ruggeri EM; Giannarelli D; Bria E; Carlini P; Felici A; Nelli F; Gallucci M; Cognetti F; Pollera CF
    Cancer; 2006 Feb; 106(4):783-8. PubMed ID: 16419069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy for bladder cancer. Standard of care or unproven therapy?
    Bahnson RR; Smith D; Trump D
    Surg Oncol Clin N Am; 1995 Apr; 4(2):287. PubMed ID: 7796287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on chemotherapy for advanced bladder cancer.
    Rosenberg JE; Carroll PR; Small EJ
    J Urol; 2005 Jul; 174(1):14-20. PubMed ID: 15947569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Herr HW
    Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of muscle-invasive bladder cancer: progress and new challenges.
    Herring JC; Kamat AM
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1047-56. PubMed ID: 15606332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    Parekh DJ; Bochner BH; Dalbagni G
    J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
    Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of bladder cancer.
    Sharma S; Ksheersagar P; Sharma P
    Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF; Nelli F
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic options and treatment of muscle invasive bladder cancer.
    O'Connor RC; Alsikafi NF; Steinberg GD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder cancer.
    Barocas DA; Clark PE
    Curr Opin Oncol; 2008 May; 20(3):307-14. PubMed ID: 18391631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy in invasive bladder cancer.
    Bamias A; Dimopoulos MA
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):993-1000. PubMed ID: 16336090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
    Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
    Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.